Streptomyces species and related genera synthesize a large number of second
ary metabolites, many of which are biologically active. Amongst them, polyk
etides is the largest class. Polyketides are a structurally diverse family
of natural products with a broad range of biological activities. The format
ion of polyketides is very similar to the biosynthesis of long chain fatty
acids - both in the enzymatic reactions that take place and the enzyme prot
eins that are involved. During the last decade many polyketide gene-cluster
s have been cloned and sequenced. DNA sequencing has shown that the cluster
s have substantial homology suggesting that they originated from a common a
ncestor. This similarity has resulted in the development of combinatorial b
iology techniques to create novel chemical entities. Two approaches have be
en used: targeted manipulation, e.g. disruption and, often, replacement of
certain genes involved in the biosynthetic pathway, and the random approach
, e.g. "gene shuffling". A targeted approach has been used to generate seve
ral novel scaffolds by manipulation of the S. rimosus oxytetracycline gene-
cluster. Genes encoding ketosynthase, alpha and beta, ketoreductase, cyclas
e/aromatase and C-6 hydroxylase were disrupted to construct four recombinan
t strains. Thin layer chromatography and high pressure liquid chromatograph
y of extracts from fermentation broths of all four recombinants showed that
they produce about 20 potentially novel metabolites, 12 of which have been
characterised chemically. In this review, data on the disruption and repla
cement of the otcC gene will be described in more detail.